Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Gross Margin (2016 - 2025)

Iradimed (IRMD) has disclosed Gross Margin for 13 consecutive years, with 75.06% as the latest value for Q4 2025.

  • Quarterly Gross Margin fell 107.0% to 75.06% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 76.75% through Dec 2025, down 19.0% year-over-year, with the annual reading at 76.75% for FY2025, 19.0% down from the prior year.
  • Gross Margin for Q4 2025 was 75.06% at Iradimed, down from 77.8% in the prior quarter.
  • The five-year high for Gross Margin was 79.71% in Q2 2022, with the low at 74.74% in Q2 2021.
  • Average Gross Margin over 5 years is 76.86%, with a median of 76.71% recorded in 2023.
  • The sharpest move saw Gross Margin skyrocketed 497bps in 2022, then plummeted -416bps in 2023.
  • Over 5 years, Gross Margin stood at 77.91% in 2021, then decreased by -3bps to 75.49% in 2022, then grew by 2bps to 76.86% in 2023, then decreased by -1bps to 76.13% in 2024, then dropped by -1bps to 75.06% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 75.06%, 77.8%, and 78.17% for Q4 2025, Q3 2025, and Q2 2025 respectively.